Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
The Oncologist|July 15, 2026
Fertility Treatment Using Assisted Reproductive Technology During Immune Checkpoint Inhibition: Report of Two CasesKeri Tomechko, Tali Azenkot, Deirdre A Conway, et al.
Translational Lung Cancer Research|April 11, 2022
Clinicopathologic and molecular characteristics of <i>EGFR</i>-mutant lung adenocarcinomas that transform to small cell lung cancer after TKI therapyLi Yu, Lyudmila Bazhenova, Kathryn Gold, et al.
Clinical Lung Cancer|June 25, 2020
Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non-Small-Cell Lung CancerJarushka Naidoo, Mizuki Nishino, Sandip Pravin Patel, et al.
JCO Clinical Cancer Informatics|March 19, 2024
Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell Lung Cancer in Administrative Claims DatabasesSandip Pravin Patel, Rongrong Wang, Summera Qiheng Zhou, et al.
Oncology|October 31, 2019
Landscape of Immune-Related Pneumonitis in Cancer Patients with Asthma Being Treated with Immune Checkpoint BlockadeJessica Galant-Swafford, Adrien Troesch, Lisa Tran, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Impact of Integrating Rumke Statistics to Assist with Choosing Between Automated Hematology Analyzer Differentials vs Manual DifferentialsLaura Stephens, Wendy Hintz-Prunty, Hans-Inge Bengtsson, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical modelsSandip Pravin Patel, Andrew Bristol, Olga Saric, et al.
Frontiers in Oncology|January 28, 2026
Unlocking the potential of immunotherapy for patients with resectable non-small cell lung cancerSandip Pravin Patel, Justin Gainor, Steven Kao, et al.
JCO Precision Oncology|May 15, 2025
Real-World Analysis of Disparities in Biomarker Testing and Use of Recommended Targeted Therapies in Metastatic Non-Small Cell Lung Cancer in the United StatesMichael J Dennis, Devin Abrahami, Maria Cecilia Vieira, et al.
The Oncologist|May 28, 2017
Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer CenterAndrew Sharabi, Sangwoo Shawn Kim, Shumei Kato, et al.
Pageof 6